For: | Velikova T, Krastev B, Gulinac M, Zashev M, Graklanov V, Peruhova M. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis. World J Clin Cases 2024; 12(6): 1050-1062 [PMID: 38464930 DOI: 10.12998/wjcc.v12.i6.1050] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v12/i6/1050.htm |
Number | Citing Articles |
1 |
Qianjie Xu, Xiaosheng Li, Yuliang Yuan, Guangzhong Liang, Zuhai Hu, Wei Zhang, Ying Wang, Haike Lei. Development and validation of a nomogram for predicting immune-mediated colitis in lung cancer patients treated with immune checkpoint inhibitors: a retrospective cohort study in China. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1510053
|
2 |
Wei Ming Ong, Samiha Arulshankar, Glen Guerra, Vinna An, Suat Chin Ng. Immune-mediated Colitis – An Update for Surgeons. World Journal of Colorectal Surgery 2025; 14(3): 85 doi: 10.4103/wjcs.wjcs_21_25
|
3 |
Wen-zhe Yi, Xin-di Qian, Xiao-xuan Xu, Rong Pu, Dan Yan, Zhi-wen Zhao, Ya-ping Li, Dang-ge Wang. Dendritic cell-liposome conjugates reverse immunosuppressive tumor microenvironment for inhibiting colitis-associated colorectal cancer. Acta Pharmacologica Sinica 2025; doi: 10.1038/s41401-025-01614-7
|
4 |
Carolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, Krishnavathana Varatharajalu, Anusha Thomas, Yinghong Wang. Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management. Immunotherapy 2025; 17(4): 293 doi: 10.1080/1750743X.2025.2473305
|